Your browser doesn't support javascript.
loading
High-grade ovarian serous carcinoma patients exhibit profound alterations in lipid metabolism.
Braicu, Elena Ioana; Darb-Esfahani, Silvia; Schmitt, Wolfgang D; Koistinen, Kaisa M; Heiskanen, Laura; Pöhö, Päivi; Budczies, Jan; Kuhberg, Marc; Dietel, Manfred; Frezza, Christian; Denkert, Carsten; Sehouli, Jalid; Hilvo, Mika.
Afiliação
  • Braicu EI; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Darb-Esfahani S; On Behalf of the Tumor Bank Ovarian Cancer Network, Berlin, Germany.
  • Schmitt WD; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Tumor bank Ovarian Cancer Network, Berlin, Germany.
  • Koistinen KM; On Behalf of the Tumor Bank Ovarian Cancer Network, Berlin, Germany.
  • Heiskanen L; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Tumor bank Ovarian Cancer Network, Berlin, Germany.
  • Pöhö P; Zora Biosciences Oy, Espoo, Finland.
  • Budczies J; Zora Biosciences Oy, Espoo, Finland.
  • Kuhberg M; VTT Technical Research Centre of Finland, Espoo, Finland.
  • Dietel M; Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Frezza C; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Tumor bank Ovarian Cancer Network, Berlin, Germany.
  • Denkert C; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Sehouli J; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Tumor bank Ovarian Cancer Network, Berlin, Germany.
  • Hilvo M; MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK.
Oncotarget ; 8(61): 102912-102922, 2017 Nov 28.
Article em En | MEDLINE | ID: mdl-29262533

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article